☆ 4.5 Article

The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT

BONE MARROW TRANSPLANTATION (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells

J. Joseph Melenhorst et al.

Summary: CAR T cells redirected to target CD19 demonstrated long-lasting potential and clonal stability in two patients with chronic lymphocytic leukaemia. Highly activated CD4(+) cells emerged and dominated the CAR T cell population at later time points. These unexpected CAR T cell populations provide novel insights into anti-cancer response and long-term remission in leukaemia.

NATURE (2022)

Add to Collection

Article Medicine, General & Internal

Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors

Eric Wang et al.

Summary: This study reveals new mutations in the BTK kinase domain and occasional mutations in downstream PLC gamma 2 in patients with chronic lymphocytic leukemia who developed resistance to the noncovalent BTK inhibitor pirtobrutinib. Despite the inactivity of BTK, alternative pathways of B-cell-receptor signaling were evident.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Hematology

Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial

Olivier Tournilhac et al.

Summary: Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative strategy in high-risk relapsing chronic lymphocytic leukemia (CLL). A phase II study utilizing an MRD-driven immune-intervention algorithm successfully achieved MRD negativity at 12 months post-HSCT, leading to reduced relapse and improved survival rates for CLL patients.

HAEMATOLOGICA (2021)

Add to Collection

Article Hematology

Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures

Michael Hallek et al.

Summary: Chronic lymphocytic leukemia is a common type of leukemia in elderly patients, diagnosed through blood tests and immunophenotyping. Treatment is determined based on disease activity and stage, with different genetic and biological markers providing prognostic information.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Anthony R Mato et al.

LANCET (2021)

Add to Collection

Article Hematology

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

Thomas E. Lew et al.

Summary: Patients with double class-resistant CLL have a poor prognosis and face high clinical challenges. They are heavily pretreated, enriched for adverse disease genetics, and have a short survival period after second-line TA therapy.

BLOOD ADVANCES (2021)

Add to Collection

Article Oncology

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

Anthony R. Mato et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Hematology

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Lindsey E. Roeker et al.

BLOOD ADVANCES (2020)

Add to Collection

Article Hematology

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia

Haesook T. Kim et al.

BLOOD ADVANCES (2020)

Add to Collection

Review Immunology

Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia

Valentina Griggio et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Letter Hematology

Allogeneic transplantation in high-risk chronic lymphocytic leukemia: a single-center, intent-to-treat analysis

Almuth Hoffmann et al.

HAEMATOLOGICA (2019)

Add to Collection

Article Hematology

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

Peter Dreger et al.

BLOOD (2018)

Add to Collection

Article Oncology

Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Michel van Gelder et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)

Add to Collection

Letter Hematology

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

Isabelle Kraemer et al.

BLOOD (2017)

Add to Collection

Article Hematology

Current state of hematopoietic cell transplantation in CLL as smart therapies emerge

Mohamed A. Kharfan-Dabaja et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.